Anthony Keech
Impact in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Treatment and Management
- Surgery top 0.02%
- Lipoproteins and Cardiovascular Health
Papers in
- Surgery 95
- Lipoproteins and Cardiovascular Health 81
- Co-authors
- Colin Baigent (15 shared papers)Lisa Blackwell (5 shared papers)Adrienne Kirby (11 shared papers)Patricia M. Kearney (4 shared papers)C Pollicino (3 shared papers)John Simes (14 shared papers)T. Sourjina (2 shared papers)Jonathan Emberson (13 shared papers)
- Journals
- The Medical Journal of Australia (29 papers)Circulation (29 papers)The Lancet (12 papers)Journal of the American College of Cardiology (11 papers)Atherosclerosis (11 papers)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Anthony Keech
292 papers receiving 23.3k citations
Anthony Keech's Hit Papers
Peers
Comparison fields: 5 of 182
- Endocrinology, Diabetes and Metabolism 4.9k
- Surgery 11.6k
- Cardiology and Cardiovascular Medicine 4.2k
- Cancer Research 2.0k
- Family Practice 169
Countries citing papers authored by Anthony Keech
This map shows the geographic impact of Anthony Keech's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony Keech with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony Keech more than expected).
Fields of papers citing papers by Anthony Keech
This network shows the impact of papers produced by Anthony Keech. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony Keech. The network helps show where Anthony Keech may publish in the future.
Co-authors
The 25 scholars most cited alongside Anthony Keech, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 299 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins Hit paper breakdown → | 2005 | 4995 |
| 2 | Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials Hit paper breakdown → | 2010 | 4496 |
| 3 | Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk Hit paper breakdown → | 2019 | 615 |
| 4 | Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease Hit paper breakdown → | 2017 | 510 |
| 5 | Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial Hit paper breakdown → | 2017 | 481 |
| 6 | Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial Hit paper breakdown → | 2017 | 413 |
| 7 | 2008 | 401 | |
| 8 | 2003 | 361 | |
| 9 | 1996 | 347 | |
| 10 | 1995 | 342 | |
| 11 | Cognitive Function in a Randomized Trial of Evolocumab Hit paper breakdown → | 2017 | 339 |
| 12 | 2000 | 291 | |
| 13 | 2010 | 258 | |
| 14 | 2003 | 243 | |
| 15 | 2006 | 238 | |
| 16 | Long-Term Evolocumab in Patients With Established Atherosclerotic Cardiovascular Disease Hit paper breakdown → | 2022 | 233 |
| 17 | 2015 | 223 | |
| 18 | Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial Hit paper breakdown → | 2020 | 223 |
| 19 | 2009 | 220 | |
| 20 | 2016 | 212 |
About Anthony Keech
Anthony Keech is a scholar working on Surgery, Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Economics and Econometrics and Statistics, Probability and Uncertainty, having authored 299 papers that have together received 24.2k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (81 papers), Health Systems, Economic Evaluations, Quality of Life (33 papers), Meta-analysis and systematic reviews (19 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (18 papers), Retinal Diseases and Treatments (16 papers), Statistical Methods in Clinical Trials (11 papers), Diabetes Treatment and Management (9 papers) and Pharmaceutical Economics and Policy (7 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (4.9k citations), Surgery (11.6k citations), Cardiology and Cardiovascular Medicine (4.2k citations), Cancer Research (2.0k citations) and Family Practice (169 citations). Anthony Keech has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Colin Baigent, Lisa Blackwell, Adrienne Kirby, Patricia M. Kearney, C Pollicino, John Simes, T. Sourjina, Jonathan Emberson, Georgina Buck and R Peto. Their work appears in journals such as The Medical Journal of Australia, Circulation, The Lancet, Journal of the American College of Cardiology and Atherosclerosis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.